Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Durham

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Scientific Reports|December 1, 2024
Development of an inhalable contrast agent targeting the respiratory tract mucus layer for pulmonary ultrasonic imagingJames K Tsuruta, Patrick R Sears, Meghan E Rebuli, et al.
Plos One|September 28, 2018
Efficacy of pyrazinoic acid dry powder aerosols in resolving necrotic and non-necrotic granulomas in a guinea pig model of tuberculosisStephanie A Montgomery, Ellen F Young, Phillip G Durham, et al.
Pharmaceutical Research|September 16, 2022
Optimization and Scale Up of Spray Dried CPZEN-45 Aerosol Powders for Inhaled Tuberculosis TreatmentIan E Stewart, Phillip G Durham, Jacob M Sittenauer, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 17, 2024
Low-boiling-point perfluorocarbon nanodroplets for adaptable ultrasound-induced blood-brain barrier openingAmbre Dauba, Claire Spitzlei, Kathlyne Jayne B Bautista, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Scientific Reports|December 1, 2024
Development of an inhalable contrast agent targeting the respiratory tract mucus layer for pulmonary ultrasonic imagingJames K Tsuruta, Patrick R Sears, Meghan E Rebuli, et al.
Plos One|September 28, 2018
Efficacy of pyrazinoic acid dry powder aerosols in resolving necrotic and non-necrotic granulomas in a guinea pig model of tuberculosisStephanie A Montgomery, Ellen F Young, Phillip G Durham, et al.
Pharmaceutical Research|September 16, 2022
Optimization and Scale Up of Spray Dried CPZEN-45 Aerosol Powders for Inhaled Tuberculosis TreatmentIan E Stewart, Phillip G Durham, Jacob M Sittenauer, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 17, 2024
Low-boiling-point perfluorocarbon nanodroplets for adaptable ultrasound-induced blood-brain barrier openingAmbre Dauba, Claire Spitzlei, Kathlyne Jayne B Bautista, et al.
Pageof 10